Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations

Alfredo Adán,1 Francisco Cabrera,2 Marta S Figueroa,3 Enrique Cervera,4 Francisco J Ascaso,5 Patricia Udaondo,6 Maximino Abraldes,7 Miguel Ángel Reyes,8 Marta Pazos,1 Bernardete Pessoa,9 Félix Armadá10 1Hospital Clínic de Barcelona, Barcelona, S...

Full description

Bibliographic Details
Main Authors: Adán A, Cabrera F, Figueroa MS, Cervera E, Ascaso FJ, Udaondo P, Abraldes M, Reyes MÁ, Pazos M, Pessoa B, Armadá F
Format: Article
Language:English
Published: Dove Medical Press 2020-07-01
Series:Clinical Ophthalmology
Subjects:
diabetic macular edema
dme
fluocinolone acetonide implant therapy
iluvien
Online Access:https://www.dovepress.com/clinical-decision-criteria-to-identify-recurrent-diabetic-macular-edem-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/clinical-decision-criteria-to-identify-recurrent-diabetic-macular-edem-peer-reviewed-article-OPTH

Similar Items